Introduction
Glutamate, which is released in the synaptic cleft during neuronal activity, is the predominant excitatory neurotransmitter in the mammalian CNS. Extracellular glutamate is taken up against its concentration gradient by excitatory amino-acid transporters such as GLAST and GLT-1. These transporters are mainly expressed at the astrocytic (Rothstein et al. 1994 ) and, to a lesser degree, at the neuronal membranes (Rimmele and Rosenberg 2016) . Fast removal of glutamate from the synaptic cleft is pivotal for signal transmission accuracy and prevention of over-excitation. To date, the modulation of glutamate uptake on excitatory neurotransmission has been studied in regards to changes in astrocytic coverage (Oliet et al. 2001) , and action of pharmacological inhibitors (Maki et al. 1994; Iserhot et al. 2004; Tsukada et al. 2005) . Here, however, we evidenced and characterized physiological modulation of glutamate transport itself.
Glutamate transport is driven by the inwardly directed Na + gradient across the plasma membrane (Levy et al. 1998; Danbolt 2001) . Transporting one glutamate into the cell is electrogenic as it is accompanied by the uptake of 3 Na + and one H + , and by the extrusion of one K + (Brew and Attwell 1987; Szatkowski et al. 1990; Barbour et al. 1994; Zerangue and Kavanaugh 1996; Bergles and Jahr 1997; Levy et al. 1998 ). This release of K + is proposed to be compulsory for the glutamate transporter to start a new uptake cycle (Kanner 2006) . Transporters of other neurotransmitters such as GABA or homologs of glutamate transporters from prokaryotes do not share this K + component (Slotboom et al. 1999; Kanner 2006) . During neuronal activity, K + is released from repolarizing neurons, as well as extruded from AMPA and NMDA receptors (AMPAR, NMDAR) at the synaptic cleft (Shih et al. 2013 (Rossi et al. 2000) . One glutamate taken up by glutamate transporter is linked to the efflux of one K + into the extracellular space at the time K + needs to be cleared out of the extracellular space. Thus, the 2 functions work against each other regarding K + movements.
The aim of this study was to investigate the cross-talk between glutamate transport and [K + ] o , and its functional consequences. In particular, we investigated the impact of altered [K + ] o on glutamate transporter activity, monitored in primary astrocytes, HEK293 cells expressing GLT-1, and in astrocytes of mouse acute cortical slices. We then evaluated the functional outcome of these interactions on neuronal function in acute cortical slices. We demonstrate for the first time that [K + ] o exerts tight control over the kinetics of the glutamate transporter. A moderate increase in [K + ] o , as observed in physiological conditions, scales down glutamate uptake. This reduced glutamate clearance decreases neurotransmission notably through activation of mGluRs, inhibiting presynaptic glutamate release. These findings reveal a novel negative feedback cascade linking [K + ] o elevation, glutamate transporter inhibition, and presynaptic mGluR activation, which together provide the basis for a previously unseen activity-dependent neuromodulatory mechanism.
Material and Methods

Animals
All experimental procedures were approved by the Veterinary Affairs Office of the Canton of Vaud, Switzerland (authorization number 1288.5-6) and were conducted in strict accordance with the animal care guidelines outlined in the Swiss Ordinance on Animal Experimentation in order to minimize the number and suffering of animals used in all experiments of this study.
Cell Culture
Cortical astrocytes in primary culture were prepared from 1-to 3-days-old C57BL/6 mice as described elsewhere (Sorg and Magistretti 1992) . Astrocytes were plated on coverslips and cultured for 3-4 weeks in DME medium (DMEM) plus 10% FCS before experiments. HEK293 cells stably expressing GLT-1 (HEK-GLT-1) were also cultured in DMEM, and plated on coverslips the day before experiments.
Fluorescence Imaging and Astrocyte Transfection
Low-light level fluorescence imaging was performed on an inverted epifluorescence microscope (Axiovert 100 M, Carl Zeiss) using a 40 × 1.3 N.A. oil-immersion objective lens. Fluorescence excitation wavelengths were selected using a monochromator (Till Photonics) and fluorescence was detected using a 12-bit cooled CCD camera (Princeton Instruments) or EM-CCD camera (Andor). Image acquisition was computer-controlled using Metafluor software (Molecular Devices). Dye-loaded cells were placed in a thermostated chamber designed for rapid exchange of perfusion solutions (Chatton et al. 2000) and superfused at 35°C.
Experimental solutions contained (mM) NaCl, 135; KCl, 5.4; NaHCO 3 , 25; CaCl 2 , 1.3; MgSO 4 , 0.8; and NaH 2 PO 4 , 0.78, glucose, 5, bubbled with 5% CO 2 /95% air. Bicarbonate-free HEPES-solutions contained (mM) NaCl, 160; KCl, 5.4; HEPES, 20; CaCl 2 , 1.3; MgSO 4 , 0.8; NaH 2 PO 4 , 0.78; glucose, 5; bubbled with air. When using different K + concentrations (3-15 mM), NaCl was adjusted to maintain isotonicity. Solutions for dye loading contained (mM) NaCl, 160; KCl, 5.4; HEPES, 20; CaCl 2 , 1.3; MgSO 4 , 0.8; NaH 2 PO 4 , 0.78; glucose, 20 and were supplemented with 0.1% Pluronic F-127 (Molecular Probes). In experiments involving more than one solution application, the order was alternated between experiments in order to exclude order-related effects. For Na + imaging experiments, astrocytes were loaded at 37°C for 40 min with the Na + -sensitive indicator Asante Natrium Green-1 acetoxymethyl ester (ANG-1, 10 µM, TEFLabs) (Lamy and Chatton 2011) . ANG-1 fluorescence was excited at 515 nm and detected at 535-585 nm. For in situ calibration, cells were permeabilized for monovalent cations using 10 μg/ml monensin, 3 μg/ml gramicidin with simultaneous inhibition of the Na + /K + -ATPase by 1 mM ouabain as described earlier (Chatton et al. 2000) . This ouabain concentration causes maximal inhibition of Na + /K + -ATPase. Cells were then sequentially perfused with solutions buffered at pH 7.2 with 20 mM HEPES and containing 0, 5, 10, 20, 50, 100 mM Na + , respectively, and 30 mM Cl − , 135 mM gluconate with a constant total concentration of Na + and K + of 160 mM. Experiments using Sodium binding benzofuran isophthalate-acetoxymethyl ester (SBFI, Teflabs) were performed as described before (Chatton et al. 2000) . Intracellular Mg 2+ was monitored using the fluorescent probe Magnesium Green-AM (MgG, Invitrogen), loaded at 37°C for 20 min with 14 µM dye. MgG fluorescence was imaged as previously described (Magistretti and Chatton 2005) . For intracellular ATP level measurements, astrocytes were treated with 3/2 ratio of Lipofectamine (Life Technologies) and DNA encoding for FRET sensor AT1.03 (ATeam cyto, Imamura et al. 2009 ). After 4 h, the medium was changed with DMEM plus 10% FCS and cells were used for experiments 2 days after transfection.
chamber was attached to a Zeiss LSM510 Meta upright microscope equipped with infrared-differential interference contrast and allowing for visualization of SR101-labeled cells. Astroglial cells were selected in layer II/III by their small soma size (<10 µm) and SR101 staining, and then recorded in whole-cell configuration. They were identified by their linear currentvoltage (I-V) relationship, the lack of action potentials, and their characteristic negative resting potential (−77.8 ± 0.6 mV). External ACSF solution contained (in mM): NaCl 125, KCl 3, NaHCO 3 26, CaCl 2 2, MgCl 2 2, NaH 2 PO 4 1.25, glucose 10 and bubbled with 95% O 2 , 5% CO 2 .
Whole-cell patch-clamp was obtained with borosilicate glass pipettes (>8 MΩ, 4-6 MΩ and 5-7 MΩ resistance for layer III neurons, astrocytes, and HEK-GLT-1 cells, respectively). The patchclamp intracellular solution contained (in mM): K-gluconate 124, NaCl 6, KCl 6, MgCl 2 3, EGTA 1, CaCl 2 0.5, HEPES 10, glutathione 2, Mg-ATP 3, and Na 3 -GTP 0.3 for astrocytes and K-gluconate 120, NaCl 5, KCl 5, MgCl 2 1, EGTA 0.1, CaCl 2 0.025, HEPES 10, glucose 4, Mg-ATP 1, and Na 3 -GTP 0.2 for neurons (pH 7.3 with KOH, 290 mOsm). Recordings were obtained in voltage-clamp configuration using a Multiclamp 700B amplifier (Molecular Devices) in gap-free mode with a holding potential set at −80 mV. Data were acquired at 10 kHz and filtered at 2 kHz by a Digidata 1440 analog-to-digital converter, controlled with the pCLAMP 10 software. Criteria for experiment inclusion in data analysis were based on the verification of stable access resistance and stable injected current (≤100 pA at −80 mV in 3 mM K + solution).
During electrophysiological experiments for assessment of the glial glutamate uptake in acute brain slices, D-AP5 (50 μM) was applied 5 min before the onset of recordings and throughout the experiment. External solutions of 3 mM, 5.4 mM, and 8 mM K + were sequentially superfused in randomized order over HEK-GLT-1 cells or acute slices. For each of these conditions, and after the measured current stabilized, the same solution with either 200 µM glutamate (HEK-GLT-1 cells) or 1 mM Daspartate (D-Asp, acute brain slices) was delivered in the bath until maximal response was observed.
To measure the effect of increased [K + ] o on the excitatory neurotransmission in acute brain slices, we recorded miniexcitatory post-synaptic currents and potentials (mEPSCs and mEPSPs) from layer II/III neurons in the whole-cell patch-clamp configuration in 3 versus 6 mM K + . Recordings were performed in presence of tetrodotoxin (TTX, 1 μM) and bicuculline (60 μM) to block Na v channels and spiking activity, and GABAergic neurotransmission, respectively. The holding potential for mEPSC recordings was −80 mV. No current was injected for mEPSP recording, allowing the membrane potentials of cells to vary upon different [K + ] o applications. For mEPSC/P recordings, each condition was monitored for 10 minutes and the last 2 were analyzed. Cells included in the analysis had a membrane potential <−55 mV or <150 pA of current injected for a voltage held at −70 mV, stable access resistance, and recovery after washout. mEPSCs were primarily mediated by non-NMDA glutamate receptor activation, as they were blocked by application of the non-NMDA glutamate receptor antagonist CNQX (10 µM), but not by the application of the NMDAR antagonist D-AP5 (50 µM) nor the presence of the GABAR antagonist bicuculline (60 µM, data not shown).
Data Analysis and Statistics
Fluorescence intensity traces were drawn from up to 10 individual cells from the field of view. Current amplitude measurements were assessed using Clampfit (Molecular Devices). mEPSCs median amplitudes and mean frequencies were measured after automatic detection followed by manual editing of the events in MiniAnalysis (Synaptosoft) for baseline, test condition(s), and washout. Further calculations were done with Excel (Microsoft). Graphs, curve fitting, and statistical analyses were done using KaleidaGraph (Synergy Software). Unless otherwise indicated, a 1-way ANOVA was performed for each experimental group to assess the statistical significance against respective controls, *, **, and *** refer to P values lower than 0.05, 0.01, and 0.001, respectively. (Fig. 1C) . These findings are consistent with previous reports on [Na + ] i homeostasis revealing the involvement of Na,K-ATPase and Na,K,Cl cotransporter (NKCC) (Rose and Ransom 1996a; Bittner et al. 2011) . As described previously using SBFI, another Na + sensitive indicator (Chatton et al. 2000) , glutamate application also caused a rapid rise of [Na + ] i that returned to baseline after washout of glutamate (Fig. 1B) . ] o application, closer mimicking the in situ situation, leads to steeper and more pronounced effects. The involvement of the glutamate transporter as the direct target of K + -modulation was confirmed by using DAsp, a non-metabolized substrate of the glutamate transporters that does not activate non-NMDAR, which yielded a similar trend in amplitude, initial slope, and potentiation in acute application as they did with glutamate (see Supplementary Fig. S2 ).
[ Since glutamate transporters and the Na,K-ATPase both contribute to the shaping of the Na + response to glutamate (Chatton et al. 2000) , we investigated whether Na,K-ATPase activity was involved in the observed modulatory effects of
The pump inhibitor ouabain (1 mM) was applied for 1 min before superfusing astrocytes with glutamate, which caused [Na + ] i to slowly rise (Fig. 3A) . The addition of 200 µM glutamate induced a sudden acceleration of the [Na + ] i rise that lasted until glutamate washout. Figure 3B shows that during Na,K-ATPase inhibition, the response slope was markedly larger in 3 versus 5.
In a further analysis, the rate of [Na + ] i rise (i.e., local slope) was plotted against time (see Supplementary Fig.  S4 ) and showed a significantly higher slope in the first minute of glutamate-induced Na + response for lower [K + ] o . This analysis also showed that the decline of Na + influx rate, i.e., transporter deactivation (Chatton et al. 2000) , occurred in both situations and tended to converge over time. Under our experimental conditions, the rodent Na,K-ATPase is rapidly and completely blocked by application of a high concentration of ouabain (1 mM) consistent with both experimental (O'Brien et al. 1994; Chatton et al. 2000 Chatton et al. , 2003 and modeling (Chatton et al. 2000) results. These experiments indicate that the effects of [K + ] o on the response to glutamate do not require Na,KATPase activity and point to an effect on glutamate transporter itself. was inhibited by bath application of the specific glutamate transporter inhibitor TFB-TBOA (200 nM, see Supplementary  Fig. S5 ) (Shimamoto et al. 2004; Bozzo and Chatton 2010 ] o also affected astrocyte responses in situ. We recorded astrocytes of layer II/III mouse cortex in the whole-cell patch-clamp configuration. Astrocytes were clamped at −80 mV and membrane currents recorded (Fig. 4C) . We found that bath application of D-Asp (1 mM) in the presence of NMDAR antagonist D-AP5 caused a marked inward current that TFB-TBOA could inhibit by 81% (see Supplementary  Fig. S5 ), confirming that glutamate transporters are responsible for the observed response induced by D-Asp. Figure 4D ] o increases alone decreased ATP hydrolysis (see Supplementary Fig. S6A,B) , an observation compatible with Na, K-ATPase activity changes (Fig. 3) . We then found that increasing [K + ] o negatively modulated both the amplitude of the ATP hydrolysis response (see Supplementary Fig. S6C,D) and the drop of cytosolic ATP levels (see Supplementary Fig. S6F ,G) ] o elevations of 3 mM from baseline are very likely to occur during non-pathological neuronal activity (Heinemann and Lux 1977) . Such a change falls within the range of~50% inhibition of the astrocytic glutamate transporter associated current according to our measurements (Fig. 4D) . As an initial hypothesis, one could expect synaptic transmission to be potentiated (Fig. 5D,F) . Representative cumulative percentile histograms (Fig. 5E) Glutamate spillover occurring consecutively to pharmacological inhibition of glutamate transporters (Maki et al. 1994; Iserhot et al. 2004; Tsukada et al. 2005) or in a brain region with decreased glial coverage (Oliet et al. 2001 ) has been proposed to decrease glutamate release via presynaptic mGluR activation. The inhibitory effect of increased [K + ] o on glutamate transport could mobilize similar mechanisms. We targeted group II metabotropic receptors, associated with G i proteins, known to decrease the probability of glutamate release upon activation. These receptors are expressed in the mouse neocortex (Reid and Romano 2001) . Figure 5B shows the representative mEPSCs traces at 3 and 6 mM [K + ] o in the presence of LY341495 (50 nM), the specific and potent antagonist of group II mGluRs (Kingston et al. 1998 ) and the corresponding averaged individual event trace of mEPSCs (Fig. 5D , middle). LY341495 application itself had no significant effect on either frequency or amplitude (data not shown Fig. 5C ). Electrophysiologically characterized cells were depolarized by −6.94 ± 1.51 mV (P < 0.01, n = 6, data not shown) in increased ] o while the amplitude of these excitatory events was not significantly different from the baseline (Fig. 5D bottom) -associated membrane depolarization could also modify glutamate neurotransmission from the presynaptic side via the presynaptic voltage dependent calcium (Ca v ) channels. To test this hypothesis, mEPSCs were recorded in the presence of the Ca v blockers ω-agatoxin-TK (120 nM) and SNX-482 (60 nM), specific blockers of the presynaptic subtypes, the P/Q type Ca v 2.1 and R type Ca v 2.3, respectively (Teramoto et al. 1997; Newcomb et al. 1998 ). This set of experiments (see Supplementary Fig. S7 ] o was similar to the effects reported during pharmacological inhibition of the glutamate transporter (Maki et al. 1994; Oliet et al. 2001; Reid and Romano 2001; Iserhot et al. 2004) , which was shown to be the consequence of extrasynaptic glutamate spillover and subsequent activation of presynaptic neuronal group II mGluRs. To our knowledge, such mechanisms have not been reported in the mouse neocortex where our studies were made. We therefore tested the outcome of pharmacological inhibition of glutamate transport on synaptic neurotransmission in this brain region. TFB-TBOA was applied in 3 mM [K + ] o at 80 nM, a concentration causing a~40% inhibition of glutamate transporters (Bozzo and Chatton 2010) , and we observed a 28.6 ± 7.3% (P = 0.03, n = 4) decrease in mEPSCs frequency with no change in amplitude, recapitulating observations made in other brain regions (data not shown). increase the glutamate concentration in the synaptic cleft, we observed it ultimately leads to the overall depression of mEPSC frequency, notably via a presynaptic mechanism involving the activation of mGluR 2,3 metabotropic receptors.
[ 
/Cl
− cotransporters, and Na, K-ATPase. Astrocytes form a syncytium, and using these clearance mechanisms, they collectively perform rapid K + redistribution in the brain (Kofuji and Newman 2004) . Of particular note is the Kir4.1 channel, which is abundant in synaptic regions and perivascular endfeet (Higashi et al. 2001 ).
Interestingly, it has been demonstrated that functional Kir4.1 expression is decreased in a mouse model of Huntington's disease (HD), which leads to striatal [K + ] o elevation (Tong et al. 2014 ). This could be reversed by viral delivery of Kir4.1 channels to striatal astrocytes. In addition, there are indications of interactions between the glutamate and K + clearance mechanisms, as suggested by the demonstration of impaired glutamate uptake described in a Kir4.1 knock-out mouse model (Djukic et al. 2007 ).
] o level is~3 mM at rest, it may reach a concentration of~12 mM during epileptiform activity (Kofuji and Newman 2004) . Accordingly, our study investigated the crosstalk between glutamate transport and [K [
During activity, astrocyte processes surrounding synapses are exposed to both glutamate and K + , which are increased in the same time window. Glutamate is rapidly removed from the extracellular space both by Na + -coupled glutamate transporters, expressed at high density at the astrocyte membranes ensheathing the synaptic elements (Danbolt 2001) , and by those present at the synaptic elements themselves (Rimmele and Rosenberg 2016) .
The present study provides evidence for a K ] o effect persisted in the presence of ouabain, excluding a direct role of Na,K-ATPase, as could have been envisaged based on the reported physical and functional association between glutamate transporters and the pump (Cholet et al. 2002; Rose et al. 2009; Matos et al. 2013 (Zerangue and Kavanaugh 1996) . Transport steps occur in 2 half-cycles: first glutamate is co-transported with 3 Na + ions and 1 H + which is followed by a reorientation of the binding sites upon countertransport of K + in a "ready for uptake" position, with the outward facing side (Kanner 2006) . It has been proposed that an elevation of [K + ] o would increase the proportion of transporters in the inward-facing conformation and therefore limit the transport cycling rate (Kanner 2006) . This is supported by experiments performed with brain plasma membrane saccules, where external K + had an inhibitory effect on vesicle uptake of glutamate in the low millimolar range (Danbolt and Storm-Mathisen 1986) , which also occurred in the presence of ionophores or in the absence of transmembrane ion gradients. This K + -mediated inhibition of glutamate uptake could therefore constitute the predominant mechanism underlying the [K + ] o modulation in the present study. The structural basis for glutamate transport function is under thorough research, among which investigations focused on the K + binding site. Targeted mutations in the K + binding site preventing binding caused the abortion of the glutamate transport cycle of the mutated GLT-1 (Kavanaugh et al. 1997) . These experiments suggest that interfering with the countertransport of K + might impede the rate of glutamate transport.
An additional model reviewed by Vandenberg and Ryan (2013) proposed ] omodulated decrease of glutamate uptake will cause a corresponding reduced Na,K-ATPase response, and associated ATP hydrolysis.
At the level of neuronal network activity, the pharmacological impairment of glutamate transporter activity is reported to favor glutamate accumulation and spillover (Tsukada et al. 2005) . Accordingly, increased [K + ] o and its inhibitory action on glutamate transporters would also be very likely to lead to comparable glutamate accumulation in addition to cell membrane depolarization. Rather than potentiating synaptic glutamate transmission, we found that a moderate increase in [K + ] o caused a depression of excitatory presynaptic transmission via an indirect mechanism, involving a decrease in synaptic vesicle release probability. To test this hypothesis in our conditions, we applied LY341495, a potent antagonist of group II mGluR (Kingston et al. 1998) , which completely abolished the depressive effect of increased [K + ] o on mEPSCs frequency. Our findings are consistent with previous studies employing a pharmacological inhibition of glutamate uptake and reporting a depression of excitatory synaptic transmission due to the activation of group II mGluRs (Maki et al. 1994; Reid and Romano 2001; Iserhot et al. 2004) . Group II mGluR encompasses mGluR 2 , 3 which have been shown to be expressed in the adult mouse cerebral cortex (Reid and Romano 2001; Renger et al. 2002) , mainly at the neuronal presynaptic membrane (Jin et al. 2016) . These G i/o coupled receptors are reported to inhibit cAMP signaling and, downstream, neurotransmitter release (Benneyworth et al. 2007) 
Conclusion
We show that the glutamate concentration in the synaptic cleft does not only depend on calcium dependent release, but also on the [K + ] o -dependent control of glutamate uptake. These 2 parameters happen to be linked, as we unveiled a novel negative feedback cascade linking [K + ] o elevation, glutamate transporter inhibition, and presynaptic mGluR activation. This mechanism depicted in Figure 6 could be fundamental for efficiently constraining excitatory neuronal activity in presence of raising [K + ] o , likely to occur during sustained neuronal activity. This study shows that the K + -coupling of glutamate transport represents a way of tuning synaptic transmission, not envisaged to date.
While the role of glutamate transporter in brain tissue is extensively studied-notably in the context of pathologies-it is with the general assumption that its transport capabilities are mainly determined by its level and pattern of expression. In this study, we unveil that these parameters are not the only determinants of glutamate uptake efficiency. [K + ] o is known to have a strong impact on neuronal excitability, and is also altered in several pathologies such as epilepsy (Frohlich et al. 2008 ) and HD (Tong et al. 2014 ). Now [K + ] o , as a physiological modulator of glutamate transport, must also be considered when studying glutamate transport efficiency. The subtle interplay between K + and glutamate transport in both physiological and pathological conditions is of paramount importance and needs to be considered to better understand glutamate homeostasis.
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